Effect of various types of antihypertensive therapy on elasticity of arterial wall in elderly patients with hypertensive disease and nonvalvular atrial fibrillation

Kardiologiya

Volumn 52, Issue 8, 2012, Pages 33-37

  Shevelev, V I ^a   Kanorsky, S G ^a  

^a KUBAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Antihypertensive therapy; Arterial wall stiffness; Atrial fibrillation; Elderly age

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGE; AGED; ARTERIAL STIFFNESS; ARTICLE; CAROTID ARTERY; COMPARATIVE STUDY; DRUG EFFECT; ECHOGRAPHY; ELASTICITY; ELASTOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MALE; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ATRIAL FIBRILLATION; CAROTID ARTERIES; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; TREATMENT OUTCOME; VASCULAR STIFFNESS;

EID: 84871875210     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Boulourie P., Tropeano A.I., Asmar R. et al. Aortic stiffness is independent predictor of priinary coronary events in hypertensive patients: a longitudinal study. Hypertens 2002;39:10-15.
2. Agabiti-Rosei Mancia G., O'Rourke M.F. et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertens 2007;50:154-160.
3. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program. JAMA 1991;265:3255-3265.
4. Dahlof B., Devereux R.B., Kjeldsen S.E. et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint Reduction in Hypertension Study (LIFE): a randomized trial against atenolol. Lancet 2002; 359: 995-1003.
5. William B., Lacy P.S., Thorn S.M. et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) Study. Circulation 2006; 113: 1213-1225.
6. Stomzhakov G.I., Vereshchagin G.S., Chervyakova J.B., Fedolov, N.M. Evaluation of elastic properties of the arterial wall in hypertensive patients younger age. Arter hypertension 2005; 1:33-36. Russian
7. Harlqff A., Strecker C, Reinhard M. et al. Combined measurement of carotid stiffness and intima-media thickness improves prediction of complex aortic plaques in patients with ischemic stroke. Stroke 2006;37:2708-2712.
8. Sugtoka K., Hozumi T., Sciacca R. et al. Impact of aortic stiffness on ischemic stroke in elderly patients. Stroke 2002;33:2077-2081.
9. Leiyuk V.G., Leiyuk S.E. Ultrasonic Angiology. 3rd ed., Revised, and add. M: Real Time, 2007; 416. Russian
10. McEniery CM., McDonnell B.J., So A. et al. Aortic calcification is assotiated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertens 2009;53:524-531.
11. Millar JA., Lever A.F., Burke V. Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J. Hypertens 1999;17:1065-1072.
12. DomanskiM.J., Davis B.R., PfefferM.A. et al. Isolated systolic hypertension prognostic information provided by pulse pressure. Hypertens 1999;34:375-380.
13. Mackenzie J.S., McEniery CM., Dhakam Z. et al. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertens 2009;54 409-413.
14. Karalliedde J., Smith A., DeAngelis L. et al. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering. Hypertens 2008;51:1617-1623.
15. Dart A.M., Cameron J.D., Gatzka CD. et al. Similar effects of treatment on central and brachial blood pressure in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertens 2007;49:1242-1247.
16. Mitchell G.F., Dunlap M.E., Wamica W. et al. Long-term trandolapril treatment is assotiated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodinamic substudy. Hypertens 2007;49:1271-1277.
17. Messerii F.H., Bangalore S., Ruschitzka F. Angiotensin receptor blockers: baseline therapy in hypertension? Eur Heart J 2009; 30: 2427-2430.
18. Schrader J., Luders S., Kulschewski A. et al. Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES). Stroke 2005;36:1218-1226.
19. Saviada T., Yamada H., Dahlof B., Matsubara H.; KYOTO HEART Study Group. Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study. Eur Heart J 2009; 30: 2461-2469.
20. Aronov D.M. Pleiotropic effects of statins. Cardiology 2008; 8:60-68. Russian
21. Long S.B., Blaha M.J., Blumenthal R.S., Michos E.D. Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly. Clin Interv Aging 2011;6:27-35.
22. Han S.H., Chung W.J., Kang W.C et al. Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: Comparative analysis with rosuvastatin alone by intravascular ultrasound. Int J Cardiol 2012; 158(2):217-24.
23. Mdki-Petaja K.M., Wilkinson LB. Anti-inflammatory drugs and statins for arterial stiffness reduction. Curr Pharm Des 2009;15:290-303.
24. Schmidt M., Christiansen C.F., Mehnert F. et al. Nonsteroidal antiinflammatory drug use and risk of atrial fibriUation or flutter population-based case-control study. BMJ 2011;4:d3450. doi: 10.1136/bny.d3450.